Epstein Secrets

o.cotn/news/2020/08/02/trump-health-official-hydroxychloroquine-390601> (8/2, Warmbrodt, 4.29M) reports that Assistant HHS Secretary for Health Adm. Brett Giroir "said Sunday there is no evidence that hydroxychloroquine is an effective treatment for the virus, despite President Donald Trump's continued promo

corn/b94bdd0202d14e13b934a2c1658d824c?pubid=fbi> , Giroir "said he could not recommend hydroxychloroquine" because trials "do not show any benefit." Giroir said, "We need to move on from that and talk about what is effective." Giroir "suggested that doctors would be unlikely to prescribe the drug." Gir

stributes." Cuccinelli "signed off on the move, according to two sources familiar with the situation, which constrained the role of the department's Office of Civil Rights and Civil Liberties in approving the intelligence office's work." Since the change, however, "I&A's work has drawn withering criticism. The Washington Post reported la

he anti-malaria drug." On NBC's Meet The PressVi, Giroir "said he could not recommend hydroxychloroquine" because trials "do not show any benefit." Giroir said, "We need to move on from that and talk about what is effective." Giroir "suggested that doctors would be unlikely to prescribe the drug." Giro

tributes." Cuccinelli "signed off on the move, according to two sources familiar with the situation, which constrained the role of the department's Office of Civil Rights and Civil Liberties in approving the intelligence office's work." Since the change, however, "I&A's work has drawn withering criticism. The Washington Post reported la

drug." On NBC's Meet The PressVi, Giroir "said he could not recommend hydroxychloroquine" because EFTA01658055 trials "do not show any benefit." Giroir said, "We need to move on from that and talk about what is effective." Giroir "suggested that doctors would be unlikely to prescribe the drug." Giro

tributes." Cuccinelli "signed off on the move, according to two sources familiar with the situation, which constrained the role of the department's Office of Civil Rights and Civil Liberties in approving the intelligence office's work." Since the change, however, "I&A's work has drawn withering criticism. The Washington Post reported la